Our experience in the research and development of needle-free jet injectors dates back to 1978 and has enabled us to develop unique delivery systems.
Our technologies give us a competitive edge in that, unlike other types of needle-free injectors available on the market, MIT's injectors are designed to function with low air pressure without compromising on accuracy, convenience and ease of use. Medical International Technologies' injectors for human and animal use are fully patented and are currently sold to individuals (such as veterinarians and integrators), clinics, and distributors in America, Australia, Asia and Europe.
Medical International Technologies (MIT Canada) Inc., headquartered in Montreal, specializes in the development, production, marketing, and sale of needle-free jet injectors both for humans and animals, for individual and mass vaccinations. MIT produces many different, professional, state-of-the-art needle-free injection systems that eradicate almost all of the problems associated with today’s needle delivery systems. MIT injectors are fully protected and have already received European Union certification (CE Marking), Health Canada certification (Canadian Medical Device Conformity Assessment System), and full International Organization for Standardization certification (ISO 9001 & 13485 certification) for human use. MIT’s devices are currently sold and in use in multiple countries (including but not limited to the USA, Canada, Australia, England, Holland, China, Malaysia, and Singapore).
Our Mission is to provide the veterinary and human medical communities with state of the art delivery system that ensures comfort to the patient, safety to the environment, ease of use and affordability to the user.
Our Vision is a world without needles.
MIT is continually investing in the research and development of its products by consulting and collaborating in clinical tests with renown pharmaceutical companies, universities and physicians in veterinary and human medicine.